ABL Diagnostics Strengthens Strategic Supplier Agreements to Support Accelerated Growth
WOIPPY, FRANCE, January 28, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), an innovative company specialized in microbiology and pathogen sequencing, announces the reinforcement of its strategic agreements with leading global …